Live Breaking News & Updates on Dermtech Inc

Stay updated with breaking news from Dermtech inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DermTech Announces Release Date for Fourth-quarter 2023 Financial Results

DermTech, Inc. , a leader in precision dermatology enabled by a non-invasive skin genomics technology, will host a conference call and webcast on Thursday, February 29, 2024 at 5:00 p.m. Eastern. ....

Dermtech-inc , Nasdaq , Smart-stickers , Markets ,

DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations

- Ongoing emphasis on growing revenue for the DermTech Melanoma Test

- Approximately $40 million in total operating expense reductions compared to fiscal 2022 resulting from all restructuring. ....

Bret-christensen , Nasdaq , Dermtech-inc , Dermtech-melanoma-test , Markets ,

DermTech (DMTK) Reports Positive Topline Results From a Study Evaluating the DermTech Melanoma Test Across All Skin Types

DermTech (DMTK) Reports Positive Topline Results From a Study Evaluating the DermTech Melanoma Test Across All Skin Types
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Neal-bhatia , Loren-clarke , Dermtech-inc , Nasdaq , Therapeutics-clinical-research , Dermtech-melanoma-test , Winter-clinical-dermatology-conference ,

DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types

DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Loren-clarke , Neal-bhatia , Dermtech-inc , Therapeutics-clinical-research , Nasdaq , Dermtech-melanoma-test , Winter-clinical-dermatology-conference , Pigmented-lesion-assay ,

DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay

- Trust 2 Study confirms negative predictive value of 99.7% for the foundational gene expression assay

- Optional TERT promoter mutation testing does not significantly alter sensitivity, NPV or. ....

Loren-clarke , Laurak-ferris , Dermtech-inc , Nasdaq , University-of-pittsburgh-school-medicine , Dermtech-melanoma-test , Pittsburgh-school , Pigmented-lesion-assay , Smart-stickers , Markets ,